Long-term survival after chemotherapy with cisplatinum, adriamycin and cyclophosphamide for carcinoma of the ovary
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference18 articles.
1. Cyclophosphamide plus cisplatinum in combination: treatment program for stage III or IV ovarian carcinoma;Decker;Obstetrics and Gynecology,1982
2. Advanced ovarian cancer: long term results of treatment with intensive cisplatin based chemotherapy of brief duration;Hainsworth;Annals of Internal Medicine,1988
3. Long term survival of advanced refractory ovarian carcinoma patients with small volume disease treated with intraperitoneal chemotherapy;Howell;Journal of Clinical Oncology,1987
4. Treatment of stages II, III, and IV primary surface epithelial ovarian cancers by maximum bulk tumour reduction and combined chemotherapy with cyclophosphamide, doxorubicin and cisplatin;Khanna;Clinical Radiology,1986
5. Long term results of a cisplatin containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma;Louie;Journal of Clinical Oncology,1986
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of fenugreek seeds extract on cyclophosphamide-induced histomorphometrical, ultrastructural and biochemical changes in testes of albino mice;Toxicology and Industrial Health;2011-09-23
2. Meta-analysis Comparing Cisplatin Total Dose Intensity and Survival;Gynecologic Oncology;1995-10
3. Treatment of advanced ovarian cancer: 10 years of experience;Annals of Oncology;1992-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3